Manajemen Syok Kardiogenik: Suatu Panduan Singkat Manajemen Syok Kardiogenik

Main Article Content

SIDHI LAKSONO
BENAZIER MARCELLA BESMAYA Besmaya

Abstract

The incidence of cardiogenic shock (CS) did decrease in the PCI era, but the short-term mortality is still high up to 80%. Cardiogenic shock most commonly occurs as a complication of acute myocardial infarction, but can also result from medication, heart failure, obstruction, or other pericardial and metabolic diseases. The pathophysiology of cardiogenic shock is associated with many etiologies and precipitants. CS needs to be evaluated based on the presence or absence of hypoperfusion and congestion so that further management becomes more targeted. Closer hemodynamic monitoring is needed in CS patients with hypoperfusion. In this review, we will be discussed the hemodynamic findings and evaluation of perfusion in patients with cardiogenic shock.

Article Details

How to Cite
SIDHI LAKSONO, & Besmaya, B. M. B. (2022). Manajemen Syok Kardiogenik: Suatu Panduan Singkat: Manajemen Syok Kardiogenik. Hang Tuah Medical Journal, 20(1), 107–121. https://doi.org/10.30649/htmj.v20i1.334
Section
Articles

References

Aissaoui, N., Puymirat, E., Delmas, C., Ortuno, S., Durand, E., Bataille, V., Drouet, E., Bonello, L., Bonnefoy-cudraz, E., Lesmeles, G., Guerot, E., Schiele, F., Simon, T., Danchin, N., 2020. Trends in cardiogenic shock complicating acute myocardial infarction 664–672.

Amado, J., Gago, P., Santos, W., Mimoso, J., Jesus, I. De, 2016. Cardiogenic shock: Inotropes and vasopressors. Revista Portuguesa de Cardiologia (English Edition) 35, 681–695.

Basir, M.B., Lemor, A., Gorgis, S., Taylor, A.M., Tehrani, B., Truesdell, A.G., Bharadwaj, A., Kolski, B., Patel, K., Gelormini, J., Todd, J., Lasorda, D., Smith, C., Riley, R., Marso, S., Federici, R., Kapur, N.K., O’Neill, W.W., 2022. Vasopressors independently associated with mortality in acute myocardial infarction and cardiogenic shock. Catheterization and Cardiovascular Interventions 99, 650–657.

Chioncel, O., Parissis, J., Mebazaa, A., Thiele, H., Desch, S., Bauersachs, J., Harjola, V.P., Antohi, E.L., Arrigo, M., Gal, T.B., Celutkiene, J., Collins, S.P., DeBacker, D., Iliescu, V.A., Jankowska, E., Jaarsma, T., Keramida, K., Lainscak, M., Lund, L.H., Lyon, A.R., Masip, J., Metra, M., Miro, O., Mortara, A., Mueller, C., Mullens, W., Nikolaou, M., Piepoli, M., Price, S., Rosano, G., Vieillard-Baron, A., Weinstein, J.M., Anker, S.D., Filippatos, G., Ruschitzka, F., Coats, A.J.S., Seferovic, P., 2020. Epidemiology, pathophysiology and contemporary management of cardiogenic shock – a position statement from the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure 22, 1315–1341.

Combes, A., Price, S., Slutsky, A.S., Brodie, D., 2020. Temporary circulatory support for cardiogenic shock. The Lancet 396, 199–212.

Esposito, M.L., Kapur, N.K., 2017. Acute mechanical circulatory support for cardiogenic shock: The “door to support” time. F1000Res 6, 1–8.

Fryer, M.L., Balsam, L.B., 2019. Mechanical Circulatory Support for Cardiogenic Shock in the Critically Ill. Chest 156, 1008–1021.

Fuernau, G., 2019. Lactate and other biomarkers as treatment target in cardiogenic shock. Current Opinion in Critical Care 25, 403–409.

Guarracino, F., Bertini, P., Pinsky, M.R., 2019. Cardiovascular determinants of resuscitation from sepsis and septic shock. Critical Care 23, 1–13.

Harjola, V.P., Lassus, J., Sionis, A., Køber, L., Tarvasmäki, T., Spinar, J., Parissis, J., Banaszewski, M., Silva-Cardoso, J., Carubelli, V., Di Somma, S., Tolppanen, H., Zeymer, U., Thiele, H., Nieminen, M.S., Mebazaa, A., 2015. Clinical picture and risk prediction of short-term mortality in cardiogenic shock. European Journal of Heart Failure 17, 501–509.

Henry, T.D., Tomey, M.I., Tamis-Holland, J.E., Thiele, H., Rao, S. V., Menon, V., Klein, D.G., Naka, Y., Piña, I.L., Kapur, N.K., Dangas, G.D., 2021. Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock A Scientific Statement From the American Heart Association. Circulation 143, E815–E829.

Hongisto, M., Lassus, J., Tarvasmaki, T., Sionis, A., Tolppanen, H., Lindholm, M.G., Banaszewski, M., Parissis, J., Spinar, J., Silva-Cardoso, J., Carubelli, V., Di Somma, S., Masip, J., Harjola, V.P., Kober, L., Mebazaa, A., Metra, M., Sionis, A., Koniari, K., Voumvourakis, A., Karavidas, A., Sans-Rosello, J., Vila, M., Duran-Cambra, A., Bulgari, M., Lazzarini, V., Parenica, J., Stipal, R., Ludka, O., Palsuva, M., Ganovska, E., Kubena, P., Hassager, C., Bäcklund, T., Jurkko, R., Järvinen, K., Nieminen, T., Pulkki, K., Soininen, L., Sund, R., Tierala, I., Tolonen, J., Varpula, M., Korva, T., Pietilä, M., Pitkälä, A., Marino, R., Sousa, A., Sousa, C., Paiva, M., Rangel, I., Almeida, R., Pinho, T., Júlia Maciel, M., Stepinska, J., Skrobisz, A., Góral, P., 2017. Use of noninvasive and invasive mechanical ventilation in cardiogenic shock: A prospective multicenter study. International Journal of Cardiology 230, 191–197.

Jung, C., 2019. Assessment of microcirculation in cardiogenic shock. Current Opinion in Critical Care 25, 410–416.

Keller, S.P., 2019. Management of Peripheral Venoarterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock. Crit Care Med 47, 1235–1242.

Lauridsen, M.D., Rørth, R., Lindholm, M.G., Kjaergaard, J., Schmidt, M., Møller, J.E., Hassager, C., Torp-Pedersen, C., Gislason, G., Køber, L., Fosbøl, E.L., 2020. Trends in first-time hospitalization, management, and short-term mortality in acute myocardial infarction–related cardiogenic shock from 2005 to 2017: A nationwide cohort study. American Heart Journal 229, 127–137.

Levis, J.T., 2015. ECG Diagnosis: Isolated Posterior Wall Myocardial Infarction. Perm J 19, e143–e144.

Levy, B., Bastien, O., Benjelid, K., Cariou, A., Chouihed, T., Combes, A., Mebazaa, A., Megarbane, B., Plaisance, P., Ouattara, A., Splaulding, C., Teboul, J.L., Vanhuyse, F., Boulain, T., Kuteifan, K., 2015. Experts’ recommendations for the management of adult patients with cardiogenic shock. Annals of Intensive Care 5, 1–10.

Levy, B., Buzon, J., Kimmoun, A., 2019. Inotropes and vasopressors use in cardiogenic shock: When, which and how much? Current Opinion in Critical Care 25, 384–390.

Levy, B., Clere-Jehl, R., Legras, A., Morichau-Beauchant, T., Leone, M., Frederique, G., Quenot, J.P., Kimmoun, A., Cariou, A., Lassus, J., Harjola, V.P., Meziani, F., Louis, G., Rossignol, P., Duarte, K., Girerd, N., Mebazaa, A., Vignon, P., Mattei, M., Thivilier, C., Perez, P., Auchet, T., Fritz, C., Boisrame-Helme, J., Mercier, E., Garot, D., Perny, J., Gette, S., Hammad, E., Vigne, C., Dargent, A., Andreu, P., Guiot, P., 2018. Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction. J Am Coll Cardiol 72, 173–182.

Levy, B., Klein, T., Kimmoun, A., 2020. Vasopressor use in cardiogenic shock. Curr Opin Crit Care 26, 411–416.

Lipinski, M.J., 2020. Cardiogenic Shock in the Setting of Acute Myocardial Infarction: The Swinging Pendulum of Revascularization. Cardiovascular Revascularization Medicine 21, 359–360.

Mach, F., Baigent, C., Catapano, A.L., Koskinas, K.C., Casula, M., Badimon, L., Chapman, M.J., De Backer, G.G., Delgado, V., Ference, B.A., Graham, I.M., Halliday, A., Landmesser, U., Mihaylova, B., Pedersen, T.R., Riccardi, G., Richter, D.J., Sabatine, M.S., Taskinen, M.R., Tokgozoglu, L., Wiklund, O., Mueller, C., Drexel, H., Aboyans, V., Corsini, A., Doehner, W., Farnier, M., Gigante, B., Kayikcioglu, M., Krstacic, G., Lambrinou, E., Lewis, B.S., Masip, J., Moulin, P., Petersen, S., Petronio, A.S., Piepoli, M.F., Pinto, X., Raber, L., Ray, K.K., Reiner, Z., Riesen, W.F., Roffi, M., Schmid, J.P., Shlyakhto, E., Simpson, I.A., Stroes, E., Sudano, I., Tselepis, A.D., Viigimaa, M., Vindis, C., Vonbank, A., Vrablik, M., Vrsalovic, M., Gomez, J.L.Z., Collet, J.P., Windecker, S., Dean, V., Fitzsimons, D., Gale, C.P., Grobbee, D.E., Halvorsen, S., Hindricks, G., Iung, B., Jüni, P., Katus, H.A., Leclercq, C., Lettino, M., Merkely, B., Sousa-Uva, M., Touyz, R.M., Nibouche, D., Zelveian, P.H., Siostrzonek, P., Najafov, R., Van De Borne, P., Pojskic, B., Postadzhiyan, A., Kypris, L., Spinar, J., Larsen, M.L., Eldin, H.S., Strandberg, T.E., Ferrières, J., Agladze, R., Laufs, U., Rallidis, L., Bajnok, L., Gudjonsson, T., Maher, V., Henkin, Y., Gulizia, M.M., Mussagaliyeva, A., Bajraktari, G., Kerimkulova, A., Latkovskis, G., Hamoui, O., Slapikas, R., Visser, L., Dingli, P., Ivanov, V., Boskovic, A., Nazzi, M., Visseren, F., Mitevska, I., Retterstøl, K., Jankowski, P., Fontes-Carvalho, R., Gaita, D., Ezhov, M., Foscoli, M., Giga, V., Pella, D., Fras, Z., De Isla, L.P., Hagström, E., Lehmann, R., Abid, L., Ozdogan, O., Mitchenko, O., Patel, R.S., 2020. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. European Heart Journal 41, 111–188.

Mathew, R., Fernando, S.M., Hu, K., Parlow, S., Di Santo, P., Brodie, D., Hibbert, B., 2022. Optimal Perfusion Targets in Cardiogenic Shock. JACC: Advances 1, 100034.

McDonagh, T.A., Metra, M., Adamo, M., Gardner, R.S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Celutkiene, J., Chioncel, O., Cleland, J.G.F., Coats, A.J.S., Crespo-Leiro, M.G., Farmakis, D., Gilard, M., Heymans, S., 2021. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal 42, 3599–3726.

Mebazaa, A., Combes, A., van Diepen, S., Hollinger, A., Katz, J.N., Landoni, G., Hajjar, L.A., Lassus, J., Lebreton, G., Montalescot, G., Park, J.J., Price, S., Sionis, A., Yannopolos, D., Harjola, V.P., Levy, B., Thiele, H., 2018. Management of cardiogenic shock complicating myocardial infarction. Intensive Care Medicine 44, 760–773.

Mebazaa, A., Tolppanen, H., Mueller, C., Lassus, J., DiSomma, S., Baksyte, G., Cecconi, M., Choi, D.J., Cohen Solal, A., Christ, M., Masip, J., Arrigo, M., Nouira, S., Ojji, D., Peacock, F., Richards, M., Sato, N., Sliwa, K., Spinar, J., Thiele, H., Yilmaz, M.B., Januzzi, J., 2016. Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance. Intensive Care Medicine 42, 147–163.

Naidu, S.S., Baran, D.A., Jentzer, J.C., Hollenberg, S.M., van Diepen, S., Basir, M.B., Grines, C.L., Diercks, D.B., Hall, S., Kapur, N.K., Kent, W., Rao, S. V., Samsky, M.D., Thiele, H., Truesdell, A.G., Henry, T.D., 2022. SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association. J Am Coll Cardiol 79, 933–946.

O’Gara, P.T., Kushner, F.G., Ascheim, D.D., Casey, D.E., Chung, M.K., De Lemos, J.A., Ettinger, S.M., Fang, J.C., Fesmire, F.M., Franklin, B.A., Granger, C.B., Krumholz, H.M., Linderbaum, J.A., Morrow, D.A., Newby, L.K., Ornato, J.P., Ou, N., Radford, M.J., Tamis-Holland, J.E., Tommaso, C.L., Tracy, C.M., Woo, Y.J., Zhao, D.X., 2013. 2013 ACCF/AHA guideline for the management of st-elevation myocardial infarction: A report of the American college of cardiology foundation/american heart association task force on practice guidelines. J Am Coll Cardiol 61, 78–140.

Reyentovich, A., Barghash, M.H., Hochman, J.S., 2016. Management of refractory cardiogenic shock. Nature Reviews Cardiology 13, 481–492.

Rui, Q., Jiang, Y., Chen, M., Zhang, N., Yang, H., Zhou, Y., 2017. Dopamine versus norepinephrine in the treatment of cardiogenic shock: A PRISMA-compliant meta-analysis. Medicine 96, e8402.

Saxena, A., Garan, A.R., Kapur, N.K., O’Neill, W.W., Lindenfeld, J., Pinney, S.P., Uriel, N., Burkhoff, D., Kern, M., 2020. Value of Hemodynamic Monitoring in Patients with Cardiogenic Shock Undergoing Mechanical Circulatory Support. Circulation 1184–1197.

Shah, R.U., De Lemos, J.A., Wang, T.Y., Chen, A.Y., Thomas, L., Sutton, N.R., Fang, J.C., Scirica, B.M., Henry, T.D., Granger, C.B., 2016. Post-hospital outcomes of patients with acute myocardial infarction with cardiogenic shock findings from the NCDR. J Am Coll Cardiol 67, 739–747.

Squara, P., Hollenberg, S., Payen, D., 2019. Reconsidering Vasopressors for Cardiogenic Shock: Everything Should Be Made as Simple as Possible, but Not Simpler. Chest 156, 392–401.

Tewelde, S.Z., Liu, S.S., Winters, M.E., 2018. Cardiogenic Shock. Cardiology Clinics 36, 53–61.

Thiele, H., Ohman, E.M., De Waha-Thiele, S., Zeymer, U., Desch, S., 2019. Management of cardiogenic shock complicating myocardial infarction: An update 2019. European Heart Journal 40, 2671–2683.

Thiele, H., Zeymer, U., 2015. Cardiogenic shock in patients with acute coronary syndromes, The ESC Textbook of Intensive and Acute Cardiovascular Care.

Unverzagt, S., Buerke, M., A, D.W., Haerting, J., Pietzner, D., Seyfarth, M., Thiele, H., Werdan, K., Zeymer, U., Prondzinsky, R., 2015. .

Vahdatpour, C., Collins, D., Goldberg, S., 2019. Cardiogenic Shock. J Am Heart Assoc 8, 1–12.

Vallabhajosyula, Saraschandra, Kashani, K., Dunlay, S.M., Vallabhajosyula, Shashaank, Vallabhajosyula, Saarwaani, Sundaragiri, P.R., Gersh, B.J., Jaffe, A.S., Barsness, G.W., 2019. Acute respiratory failure and mechanical ventilation in cardiogenic shock complicating acute myocardial infarction in the USA, 2000–2014. Annals of Intensive Care 9.

Werdan, K., Buerke, M., Geppert, A., Thiele, H., Zwissler, B., Ruß, M., 2021. Klinische Leitlinie: Infarktbedingter kardiogener Schock - Diagnose, Monitoring und Therapie. Deutsches Arzteblatt International 118, 88–95.